Skip to Content

WATSON 347 12.5 mg (Hydrochlorothiazide 12.5 mg)

Pill imprint WATSON 347 12.5 mg has been identified as Hydrochlorothiazide 12.5 mg.

Hydrochlorothiazide is used in the treatment of high blood pressure; edema; diabetes insipidus; nephrocalcinosis; osteoporosis and belongs to the drug class thiazide diuretics. There is no proven risk in humans during pregnancy. Hydrochlorothiazide 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Hydrochlorothiazide 12.5 mg WATSON 347 12.5 mg
Hydrochlorothiazide 12.5 mg WATSON 347 12.5 mg
Hydrochlorothiazide 12.5 mg WATSON 347 12.5 mg
WATSON 347 12.5 mg
12.5 mg
Turquoise & White
14.00 mm
Prescription only
Drug Class:
Thiazide diuretics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Watson Pharmaceuticals
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
corn starch
D&C Red No. 28
D&C Yellow No. 10
FD&C Blue No. 1
lactose monohydrate
magnesium stearate
titanium dioxide
ferrosoferric oxide
FD&C Blue No. 2
FD&C Red No. 40
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5236 A-S Medication Solutions, LLC (repackager)
16590-0580 Stat RX USA LLC (repackager)
49999-0388 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.